Sprint Bioscience AB (publ)
SSE:SPRINT.ST
0.876 (SEK) • At close February 20, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) SEK.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 50.485 | 0.083 | 35.114 | 16.885 | 33.541 | 17.936 | 23.967 | 34.992 | 7.727 | 4.61 | 2.371 | 1.588 | 2.368 |
| Cost of Revenue
| 54.217 | 60.992 | 10.436 | 10.459 | 8.174 | 0.745 | 2.989 | 0.418 | -0.208 | -1.165 | -3.421 | -2.164 | 0.395 |
| Gross Profit
| -3.732 | -60.909 | 24.678 | 6.426 | 25.367 | 17.191 | 20.978 | 34.574 | 7.934 | 5.775 | 5.792 | 3.752 | 1.973 |
| Gross Profit Ratio
| -0.074 | -733.843 | 0.703 | 0.381 | 0.756 | 0.958 | 0.875 | 0.988 | 1.027 | 1.253 | 2.443 | 2.362 | 0.833 |
| Reseach & Development Expenses
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 2.885 | 0 | 0.4 | 0 | 0 | 0 |
| General & Administrative Expenses
| 0 | 0 | 22.179 | 21.108 | 18.288 | 17.216 | 13.192 | 11.059 | 9.325 | 3.77 | 3.328 | 2.617 | 0.83 |
| Selling & Marketing Expenses
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| SG&A
| 45.072 | 47.444 | 22.179 | 21.108 | 18.288 | 17.216 | 13.192 | 11.059 | 9.325 | 3.77 | 3.328 | 2.617 | 0.83 |
| Other Expenses
| 1.205 | 0 | 27.965 | 22.993 | 27.5 | 22.061 | 18.115 | 16.226 | 13.74 | 8.654 | 6.62 | 6.371 | 2.685 |
| Operating Expenses
| 44.314 | 47.322 | 50.144 | 44.101 | 45.788 | 39.277 | 31.307 | 27.285 | 23.065 | 12.425 | 9.948 | 8.988 | 3.515 |
| Operating Income
| -3.732 | -60.909 | -25.466 | -37.675 | -20.421 | -22.059 | -10.668 | 4.566 | -15.357 | -11.259 | -4.156 | -5.236 | -1.541 |
| Operating Income Ratio
| -0.074 | -733.843 | -0.725 | -2.231 | -0.609 | -1.23 | -0.445 | 0.13 | -1.988 | -2.442 | -1.753 | -3.297 | -0.651 |
| Total Other Income Expenses Net
| 3.294 | 0.739 | 0.383 | -5.117 | -1.115 | -0.13 | -0.334 | -2.747 | -0.369 | -0.204 | -0.231 | 1.691 | 0.029 |
| Income Before Tax
| -0.438 | -60.17 | -25.083 | -42.792 | -21.536 | -22.216 | -10.663 | 4.541 | -15.5 | -11.464 | -4.387 | -3.545 | -1.513 |
| Income Before Tax Ratio
| -0.009 | -724.94 | -0.714 | -2.534 | -0.642 | -1.239 | -0.445 | 0.13 | -2.006 | -2.487 | -1.85 | -2.232 | -0.639 |
| Income Tax Expense
| 0.279 | 0 | 0.269 | 3.441 | 1.208 | 0.007 | -0.292 | 0.222 | -0.224 | 0.004 | 0 | 0.002 | -0.136 |
| Net Income
| -0.438 | -60.17 | -25.352 | -46.233 | -22.744 | -22.216 | -10.663 | 4.541 | -15.5 | -11.464 | -4.387 | -3.545 | -1.377 |
| Net Income Ratio
| -0.009 | -724.94 | -0.722 | -2.738 | -0.678 | -1.239 | -0.445 | 0.13 | -2.006 | -2.487 | -1.85 | -2.232 | -0.581 |
| EPS
| -0.006 | -1.43 | -0.73 | -2.23 | -1.51 | -1.88 | -1.09 | 0.48 | -1.77 | -1.31 | -0.65 | -0.52 | -0.82 |
| EPS Diluted
| -0.006 | -1.43 | -0.73 | -2.23 | -1.51 | -1.88 | -1.09 | 0.48 | -1.77 | -1.31 | -0.65 | -0.52 | -0.82 |
| EBITDA
| -3.285 | -60.291 | -24.224 | -38.654 | -19.597 | -21.375 | -10.057 | 10.846 | -15.148 | -10.868 | -3.847 | -5.166 | -1.531 |
| EBITDA Ratio
| -0.065 | -726.398 | -0.69 | -2.289 | -0.584 | -1.192 | -0.42 | 0.31 | -1.96 | -2.358 | -1.623 | -3.252 | -0.647 |